Skip to main content

Stat-Dx Secures €20M Loan Facility

NEW YORK (GenomeWeb) – Spanish molecular diagnostics firm Stat-Dx today said that it has secured a €20 million ($22.4 million) loan facility from the European Investment Bank for the development of diagnostic tools to identify infectious pathogens.

The loan will be drawn in two tranches over a three-year period with full repayment on the maturity date five years ahead. The funds will go toward the cofinancing of a three-year project "aimed at enabling faster and more accurate diagnostics that will replace current complex protocols to obtain analytical results," Stat-Dx said.

The firm is developing a cartridge-based single test system called DiagCORE, a fully integrated and automated molecular testing platform for infectious diseases. The platform is being developed to detect pathogens such as meningitis, and respiratory or gastrointestinal infections in about one hour.

Stat-Dx plans to apply for CE marking for DiagCORE and a respiratory panel by the end of the year, it said. Initially, it plans to launch DiagCORE with molecular cartridges, which leverages real-time PCR technology, followed with a launch of immunoassay cartridges later. The intention is market the system as a combined molecular-immunoassay system. 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.